Allan Saul

Allan Saul

GlaxoSmithKline - Needham / United Kingdom
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 4370285
-
person_outline Allan Saul's MOST POPULAR ARTICLES
1-) A Recombinant Blood-Stage Malaria Vaccine Reduces Plasmodium falciparum Density and Exerts Selective Pressure on Parasite Populations in a Phase 1-2b … The Journal of infectious diseases 185 (6), 820-827, 2002
2-) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum The Lancet 360 (9333), 610-617, 2002
3-) Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51 PloS one 3 (7), e2636, 2008
4-) Mutations in Plasmodium falciparumCytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site Antimicrobial agents and chemotherapy 44 (8), 2100-2108, 2000
5-) Progress and challenges for malaria vaccines Nature 415 (6872), 694-701, 2002